To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Ketazolam
Ketazolam (marketed under brand names Anseren, Anxon, Contamex, Loftran, Marcen, Sedotime, Solatran, Unakalm) is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Additional recommended knowledgeKetazolam is not approved for sale in the United States or Canada. In South Africa, GlaxoSmithKline markets ketazolam under its Solatran trademark.[1] The U.S. Food and Drug Administration warns[2] that in Spain, ketazolam marketed as Marcen may sometimes be mistakenly confused with Narcan. Brand Names
Other namesU 28774; Anxon;[3] Contamex; Loftran; DEA No. 2772[4];
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Ketazolam". A list of authors is available in Wikipedia. |
- Moclobemide
- Tiny sensors for major advances - Using NMR spectrometry to analyse important molecules that have not been accessible before now
- Professor develops super-resolution microscopy techniques
- Evotec Reports Good Progress in Product Development in Treatment-Resistant Depression in its Alliance with Roche - Successful completion of first-in-man study with EVT 103
- Ablynx reports phase II dara for ALX-0081 in high risk ACS patients undergoing a PCI procedure